Publications by authors named "Farhad Ravandi"

100Publications

Acute promyelocytic leukemia (APL) with an fusion transcript: an aggressive APL variant.

Leuk Lymphoma 2020 Dec 11;61(12):3018-3020. Epub 2020 Jul 11.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1791853DOI Listing
December 2020

Nelarabine-related rhabdomyolysis in a patient with T-cell acute lymphoblastic leukemia.

Leuk Lymphoma 2020 Nov 11;61(11):2775-2777. Epub 2020 Jul 11.

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1791852DOI Listing
November 2020

Identifying effective drug combinations for patients with acute myeloid leukemia.

Expert Rev Anticancer Ther 2020 Jul 30;20(7):591-601. Epub 2020 Jun 30.

Department of Leukemia, MD Anderson Cancer Center , Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2020.1782749DOI Listing
July 2020

Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions.

J Hematol Oncol 2020 06 5;13(1):70. Epub 2020 Jun 5.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-020-00905-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275444PMC
June 2020

Outcome of adults with relapsed/refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma.

Am J Hematol 2020 Jun 5. Epub 2020 Jun 5.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25896DOI Listing
June 2020

Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges.

Cancer Discov 2020 Apr 3;10(4):506-525. Epub 2020 Feb 3.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-19-1011DOI Listing
April 2020

Myeloid sarcoma.

Curr Opin Hematol 2020 Mar;27(2):88-94

Department of Leukemia, University of Texas - MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000571DOI Listing
March 2020

First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL).

Leuk Lymphoma 2020 02 30;61(2):445-449. Epub 2019 Sep 30.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1660967DOI Listing
February 2020

Quizartinib in the treatment of FLT3-internal-tandem duplication-positive acute myeloid leukemia.

Future Oncol 2019 Dec 27;15(34):3885-3894. Epub 2019 Sep 27.

Department of Leukemia, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 0428 Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0353DOI Listing
December 2019

Moxetumomab pasudotox for the treatment of relapsed and/or refractory hairy cell leukemia.

Expert Rev Hematol 2019 09 1;12(9):707-714. Epub 2019 Aug 1.

Department of leukemia, The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2019.1643231DOI Listing
September 2019

How close are we to incorporating measurable residual disease into clinical practice for acute myeloid leukemia?

Haematologica 2019 08 4;104(8):1532-1541. Epub 2019 Jul 4.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.208454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669140PMC
August 2019

Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia.

Ther Adv Hematol 2019 19;10:2040620719849496. Epub 2019 May 19.

Department of Leukemia, Unit 428, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620719849496DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535741PMC
May 2019

inhibitor quizartinib (AC220).

Leuk Lymphoma 2019 08 18;60(8):1866-1876. Epub 2019 Apr 18.

a Department of Leukemia , University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1602263DOI Listing
August 2019

10-day vs 5-day decitabine: equivalence cannot be concluded - Authors' reply.

Lancet Haematol 2019 04;6(4):e178

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30052-3DOI Listing
April 2019

Emerging treatment paradigms with FLT3 inhibitors in acute myeloid leukemia.

Ther Adv Hematol 2019 15;10:2040620719827310. Epub 2019 Feb 15.

Department of Leukemia, Unit 428, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620719827310DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378516PMC
February 2019

Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Curr Treat Options Oncol 2019 01 24;20(1). Epub 2019 Jan 24.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd. Unit 0428, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11864-019-0603-z
Publisher Site
http://dx.doi.org/10.1007/s11864-019-0603-zDOI Listing
January 2019

Distinguishing thymoma from T-lymphoblastic leukaemia/lymphoma: a case-based evaluation.

J Clin Pathol 2019 Mar 22;72(3):251-257. Epub 2018 Nov 22.

Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2018-205399DOI Listing
March 2019

Is it time to routinely incorporate MRD into practice?

Authors:
Farhad Ravandi

Best Pract Res Clin Haematol 2018 12 21;31(4):396-400. Epub 2018 Sep 21.

Department of Leukemia, The University of Texas - M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 428, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2018.09.013DOI Listing
December 2018

How I treat Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:
Farhad Ravandi

Blood 2019 01 15;133(2):130-136. Epub 2018 Nov 15.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/lookup/doi/10.1182/blood-2018-08
Publisher Site
http://dx.doi.org/10.1182/blood-2018-08-832105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042663PMC
January 2019

Treatment of Acute Promyelocytic Leukemia With No or Minimal Chemotherapy: Now a Reality in Common Clinical Practice.

Authors:
Farhad Ravandi

J Oncol Pract 2018 11;14(11):663-664

The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00537DOI Listing
November 2018